| 1 |
35322385 | Correction to: The impact of IL-10 and CYP3A5 gene polymorphisms on dose-adjusted trough blood tacrolimus concentrations in early post-renal transplant recipients. | 2022 Jun |
1 |
| 2 |
35126303 | The Alteration of Circulating Lymphocyte Subsets During Tacrolimus Therapy in Neuromyelitis Optica Spectrum Disorder and Its Correlation With Clinical Outcomes. | 2021 |
1 |
| 3 |
32817992 | Tacrolimus Improves the Implantation Rate in Patients with Elevated Th1/2 Helper Cell Ratio and Repeated Implantation Failure (RIF). | 2020 Aug |
2 |
| 4 |
32932253 | Therapeutic and Immunoregulatory Effects of Tacrolimus in Patients with Refractory Generalized Myasthenia Gravis. | 2020 |
1 |
| 5 |
33039969 | The effect of genetic variations for interleukin-10 (IL-10) on the efficacy of immunosuppressive therapy in patients after kidney transplantation. | 2020 Dec |
6 |
| 6 |
30633591 | Effects of tacrolimus (FK506) and mycophenolate mofetil (MMF) on regulatory T cells and co-inhibitory receptors in the peripheral blood of human liver allograft patients. | 2019 Jun |
1 |
| 7 |
28060893 | Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis. | 2017 |
1 |
| 8 |
28246425 | Influence of IL-18 and IL-10 Polymorphisms on Tacrolimus Elimination in Chinese Lung Transplant Patients. | 2017 |
1 |
| 9 |
26471483 | Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells. | 2016 Jan |
1 |
| 10 |
27045291 | Renal Transplant Recipients Treated with Calcineurin-Inhibitors Lack Circulating Immature Transitional CD19+CD24hiCD38hi Regulatory B-Lymphocytes. | 2016 |
1 |
| 11 |
25964218 | Relationship of Interleukin-10 and Transforming Growth Factor-β Levels With Short-Term Graft Function After Kidney Transplantation. | 2015 Jun |
1 |
| 12 |
24465960 | Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR genetic polymorphisms on tacrolimus metabolism in Chinese renal transplant recipients. | 2014 |
1 |
| 13 |
24709525 | Decrease of immature B cell and interleukin-10 during early-post-transplant period in renal transplant recipients under tacrolimus based immunosuppression. | 2014 May |
1 |
| 14 |
21195813 | Clinical efficacy and immunological impact of tacrolimus in Chinese patients with generalized myasthenia gravis. | 2011 Apr |
1 |
| 15 |
21359536 | Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period. | 2011 Aug |
2 |
| 16 |
19880819 | Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation. | 2010 Oct |
1 |
| 17 |
19438859 | Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus. | 2009 Sep |
4 |
| 18 |
18262659 | Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis. | 2008 Mar |
1 |
| 19 |
17568575 | Polymorphisms of tumor necrosis factor-alpha, interleukin-10, cytochrome P450 3A5 and ABCB1 in Chinese liver transplant patients treated with immunosuppressant tacrolimus. | 2007 Aug |
3 |
| 20 |
14767008 | In vitro treatment of dendritic cells with tacrolimus: impaired T-cell activation and IP-10 expression. | 2004 Mar |
1 |
| 21 |
12176404 | Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration. | 2002 Aug |
1 |
| 22 |
12270545 | Different mechanisms are utilized by HIV-1 Nef and staphylococcal enterotoxin A to control and regulate interleukin-10 production. | 2002 Nov 1 |
1 |
| 23 |
11266931 | IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection. | 2001 Feb-Mar |
1 |
| 24 |
11084058 | Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation. | 2000 Nov |
1 |
| 25 |
10563471 | Differential IL-10 receptor gene expression in acute versus chronic atopic eczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes. | 1999 Oct |
1 |
| 26 |
9510155 | Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. | 1998 Mar 15 |
1 |
| 27 |
9800954 | Low level of interleukin 10 synthesis during liver allograft rejection. | 1998 Oct |
2 |
| 28 |
9123208 | Impaired T-cell IL-10 secretion and CD4 helper function in liver transplant patients treated with tacrolimus. | 1997 Feb-Mar |
1 |
| 29 |
9190906 | Autocrine and paracrine regulation of human T cell IL-10 production. | 1997 Jun 15 |
1 |
| 30 |
1721312 | FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. | 1991 Dec |
1 |